Derouane, F.; van Marcke, C.; Berlière, M.; Gerday, A.; Fellah, L.; Leconte, I.; Van Bockstal, M.R.; Galant, C.; Corbet, C.; Duhoux, F.P.
Predictive Biomarkers of Response to Neoadjuvant Chemotherapy in Breast Cancer: Current and Future Perspectives for Precision Medicine. Cancers 2022, 14, 3876.
https://doi.org/10.3390/cancers14163876
AMA Style
Derouane F, van Marcke C, Berlière M, Gerday A, Fellah L, Leconte I, Van Bockstal MR, Galant C, Corbet C, Duhoux FP.
Predictive Biomarkers of Response to Neoadjuvant Chemotherapy in Breast Cancer: Current and Future Perspectives for Precision Medicine. Cancers. 2022; 14(16):3876.
https://doi.org/10.3390/cancers14163876
Chicago/Turabian Style
Derouane, Françoise, Cédric van Marcke, Martine Berlière, Amandine Gerday, Latifa Fellah, Isabelle Leconte, Mieke R. Van Bockstal, Christine Galant, Cyril Corbet, and Francois P. Duhoux.
2022. "Predictive Biomarkers of Response to Neoadjuvant Chemotherapy in Breast Cancer: Current and Future Perspectives for Precision Medicine" Cancers 14, no. 16: 3876.
https://doi.org/10.3390/cancers14163876
APA Style
Derouane, F., van Marcke, C., Berlière, M., Gerday, A., Fellah, L., Leconte, I., Van Bockstal, M. R., Galant, C., Corbet, C., & Duhoux, F. P.
(2022). Predictive Biomarkers of Response to Neoadjuvant Chemotherapy in Breast Cancer: Current and Future Perspectives for Precision Medicine. Cancers, 14(16), 3876.
https://doi.org/10.3390/cancers14163876
